GIMAP2
GTPase IMAP family member 2
Also known as: DKFZp586D0824, GIMA2_HUMAN, HIMAP2, IAN12, IMAP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UG22
- Gene
- GIMAP2
- Ensembl
- ENSG00000106560
- Chromosome
- 7
- Canonical length
- 337 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Lipid droplets
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein belonging to the GTP-binding superfamily and to the immuno-associated nucleotide (IAN) subfamily of nucleotide-binding proteins. In humans, the IAN subfamily genes are located in a cluster at 7q36.1. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
337 residues, UniProt reviewed canonical sequence.
>Q9UG22|GIMAP2
1 MDQNEHSHWG PHAKGQCASR SELRIILVGK TGTGKSAAGN SILRKQAFES KLGSQTLTKT
61 CSKSQGSWGN REIVIIDTPD MFSWKDHCEA LYKEVQRCYL LSAPGPHVLL LVTQLGRYTS
121 QDQQAAQRVK EIFGEDAMGH TIVLFTHKED LNGGSLMDYM HDSDNKALSK LVAACGGRIC
181 AFNNRAEGSN QDDQVKELMD CIEDLLMEKN GDHYTNGLYS LIQRSKCGPV GSDERVKEFK
241 QSLIKYMETQ RSYTALAEAN CLKGALIKTQ LCVLFCIQLF LRLIILWLCI LHSMCNLFCC
301 LLFSMCNLFC SLLFIIPKKL MIFLRTVIRL ERKTPRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GIMAP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 73 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 73 nTPM
- spleen: 59 nTPM
- tonsil: 54 nTPM
- thymus: 47 nTPM
- appendix: 38 nTPM
- lung: 21 nTPM
Single-cell type
- kupffer cells: 203 nCPM
- monocytes: 59 nCPM
- hematopoietic stem cells: 56 nCPM
- t-cells: 49 nCPM
- thymocytes: 48 nCPM
- hofbauer cells: 47 nCPM
Immune cell
- naive CD4 T-cell: 167 nTPM
- NK-cell: 137 nTPM
- total PBMC: 130 nTPM
- naive CD8 T-cell: 125 nTPM
- memory CD4 T-cell: 122 nTPM
- non-classical monocyte: 122 nTPM
Brain region
- medulla oblongata: 11 nTPM
- white matter: 9.5 nTPM
- pons: 9 nTPM
- spinal cord: 9 nTPM
- midbrain: 7.1 nTPM
- thalamus: 6.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.69
- gnomAD pLI
- 0.41
- gnomAD missense Z
- 0.12
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GIMAP2 as an antibody target. Whether an autoantibody or antibody against GIMAP2 could matter depends on whether native GIMAP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GIMAP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GIMAP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...